Washington, DC, February 14, 2023 – A recent Ipsos poll, conducted on behalf of the EMAA Project, shows two-thirds of Americans want medication abortion to remain legal in the United States, and 62% of Americans say that banning medication abortion would harm women and their families.
A majority of Americans say they disagree with the Supreme court's decision to overturn Roe vs. Wade (56%). Democrats (80%) are much more likely than Republicans (35%) to say they disagree with the decision.
Two-thirds of Americans say that medication abortion should remain legal in the United States, including 84% of Democrats, 67% of independents, and 49% of Republicans.
When given information about the pending case in Texas concerning the FDA's approval of medication abortion, just 29% of Americans say that a federal judge should override the FDA's approval of medication abortion, banning medication abortion in the United States.
When given more information about medication abortion and the FDA approval process in the year 2000, the same proportion of Americans (66%) agree that a federal judge should allow medication abortion to remain legal, including 87% of Democrats, 65% of independents and 49% of Republicans. Sixty-two percent of Americans agree that the courts banning medication abortion would harm women and their families.
About the Study
These are some of the findings of an Ipsos poll conducted between February 9-10, 2023 on behalf of the EMAA project. For this survey, a sample of 1,005 adults age 18+ from the continental U.S., Alaska, and Hawaii was interviewed online in English. The sample includes 420 Democrats, 391 Republicans, and 117 independents.
The sample for this study was randomly drawn from Ipsos’ online panel, partner online panel sources, and “river” sampling and does not rely on a population frame in the traditional sense. Ipsos uses fixed sample targets, unique to each study, in drawing a sample. After a sample has been obtained from the Ipsos panel, Ipsos calibrates respondent characteristics to be representative of the U.S. Population using standard procedures such as raking-ratio adjustments. The source of these population targets is U.S. Census 2021 American Community Survey data. The sample drawn for this study reflects fixed sample targets on demographics. Post-hoc weights were made to the population characteristics on gender, age, race/ethnicity, region, education and political party affiliation.
Statistical margins of error are not applicable to online non-probability polls. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error and measurement error. Where figures do not sum to 100, this is due to the effects of rounding. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of plus or minus 3.8 percentage points for all respondents. Ipsos calculates a design effect (DEFF) for each study based on the variation of the weights, following the formula of Kish (1965). This study had a credibility interval adjusted for design effect of the following (n=1,005, DEFF=1.5 adjusted Confidence Interval=+/-5.3 percentage points).
The poll also has a credibility interval of plus or minus 5.9 percentage points for Democrats, plus or minus 6.1 percentage points for Republicans, and plus or minus 11.1 percentage points for independents.
For more information on this news release, please contact:
Senior Vice President, US
+1 202 420-2025 [email protected]
Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.
Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.
Our tagline "Game Changers" sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.
Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP